Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: can we define better-responding endotypes?

Overview of attention for article published in Anais Brasileiros de Dermatologia, July 2022

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 9 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 410 followers.

#urticariologists

19 Jul 2022

Reply Repost Favourite

Our new paper “Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria” emphasizes that there are certainly different endotypes of CSU which deserve different treatment approaches. https://t.co/S4CViOQ36K #urticaria #drugdev

18 Jul 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.